Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fujian Haixi Pharmaceuticals CoHKSE:02637 +3.28%23 Gross Margin % is 83.38% as of Dec. 2025, which is 0% above its 10-year median of 83.12. GuruFocus rates HKSE:02637 with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 940 Drug Manufacturers companies, Fujian Haixi Pharmaceuticals Co ranks better than 94.79% on this metric.
HKSE:02637's Gross Margin % is ranked better than 94.79% of 940
companies
in the Drug Manufacturers industry
Industry Median: 48.35
vs HKSE:02637: 83.38
Fujian Haixi Pharmaceuticals Co had a gross margin of 83.38% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Fujian Haixi Pharmaceuticals Co (HKSE:02637) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Fujian Haixi Pharmaceuticals Co had a gross margin of 83.38% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Fujian Haixi Pharmaceuticals Co Gross Margin % Related Terms
Fujian Haixi Pharmaceuticals Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fujian Haixi Pharmaceuticals Co Gross Margin % Chart
Fujian Haixi Pharmaceuticals Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Gross Margin %
80.99
83.26
82.97
83.38
Fujian Haixi Pharmaceuticals Co Semi-Annual Data
Dec22
Dec23
Dec24
Dec25
Gross Margin %
80.99
83.26
82.97
83.38
HKSE:02637 vs ZTS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Fujian Haixi Pharmaceuticals Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fujian Haixi Pharmaceuticals Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fujian Haixi Pharmaceuticals Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Fujian Haixi Pharmaceuticals Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Fujian Haixi Pharmaceuticals Co (HKSE:02637) has a Gross Margin % of 83.38% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Fujian Haixi Pharmaceuticals Co and its competitors. This is near median its historical median of 83.12. Over the past decade, Fujian Haixi Pharmaceuticals Co's Gross Margin % has ranged from 80.99 to 83.38. According to the industry distribution chart, Fujian Haixi Pharmaceuticals Co ranks #49 out of 940 companies in the Drug Manufacturers industry, placing it in the top 5.2%.
Is Fujian Haixi Pharmaceuticals Co's Gross Margin % too high?
Fujian Haixi Pharmaceuticals Co's current Gross Margin % of 83.38% is near median its 10-year median of 83.12. Over the past 10 years, this metric has ranged from a low of 80.99 to a high of 83.38. The Drug Manufacturers industry median Gross Margin % is 48.35. Fujian Haixi Pharmaceuticals Co's value of 83.38% is 72.5% above this industry median. Based on the distribution chart, Fujian Haixi Pharmaceuticals Co ranks #49 out of 940 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Fujian Haixi Pharmaceuticals Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Fujian Haixi Pharmaceuticals Co's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Fujian Haixi Pharmaceuticals Co ranks #49 out of 940 companies for Gross Margin %. This places Fujian Haixi Pharmaceuticals Co in the top 5% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.35. Fujian Haixi Pharmaceuticals Co's value of 83.38% is 72.5% above this benchmark. Historically, Fujian Haixi Pharmaceuticals Co's own Gross Margin % has ranged from 80.99 to 83.38 over the past decade. While the company's 10-year median is 83.12 vs. the industry median of 48.35, Fujian Haixi Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.35, based on 940 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fujian Haixi Pharmaceuticals Co's current Gross Margin % of 83.38% is 72.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Fujian Haixi Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fujian Haixi Pharmaceuticals Co's current Gross Margin % is 83.38%, which is near median its own 10-year median of 83.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fujian Haixi Pharmaceuticals Co stock overvalued right now?
Fujian Haixi Pharmaceuticals Co (HKSE:02637) has a current Gross Margin % of 83.38%. The current Gross Margin % is 83.38%, which is near median its 10-year median of 83.12 and 72.5% above the Drug Manufacturers industry median of 48.35. Fujian Haixi Pharmaceuticals Co's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Fujian Haixi Pharmaceuticals Co (HKSE:02637), the current Gross Margin % is 83.38% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fujian Haixi Pharmaceuticals Co Ltd is a commercial-stage pharmaceutical company that integrates R&D, production and sales capacities, with a pipeline of inventive drug candidates. It has a diversified product portfolio and pipeline in the fastest growing therapeutic areas in China. The company's commercialized product portfolio consisted of generic drugs for digestive system diseases, cardiovascular system diseases, endocrine system diseases, nervous system diseases and inflammatory diseases. Its inventive drug pipeline focuses on drug candidates in a variety of indications, including one potential first-in-class oncology drug candidate, one potential first oral drug therapy for wet age-related macular degeneration /diabetic macular edema /retinal vein occlusion.
23GF Score
Get the complete analysis for HKSE:02637
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02637 has been successfully added to your 
